The International Conference on Harmonisation (ICH), a pharmaceutical-focused regulatory harmonization group whose guidelines are widely adopted, has announced that its S1 rodent carcinogenicity ...
The author provides a review of FDA's guidance document, Guidance for Industry: Q11 Development and Manufacture of Drug Substances, and its relation to the International Conference on Harmonization's ...
This article reviews the scope, key principles, methodological expectations, and regulatory implications of ICH E20, and ...
In 2020, the International Council for Harmonisation (ICH) published a concept paper (1) that outlined a limited revision to the published guideline ICH Q9 Quality Risk Management (QRM) (2) to address ...